Lung Cancer

Welcome!

As part of Roche Israel's commitment to Lung Cancer, we have gathered here a variety of educational resources and materials for your use.

This website is provided as a service by Roche Israel and is intended for health care professionals only.

 

To access the site please login here.

You will first need to register if it's your first visit.

Immunotherapy in NSCLC
Oncology Tecentriq
International webinar with leading experts
Tecentriq Lung cancer
Join the TAE panel with Prof. Bar and Dr. Kremer
Oncology Lung cancer
IMpower010 trial highlights
Oncology Lung cancer
IMpower010 trial highlights
Tecentriq Lung cancer
Breakthrough in the treatment of early-stage lung cancer
Tecentriq Lung cancer
Prof. Amir On, Director of the Lung Disease Institute at Sheba Hospital, Tel Hashomer
Alecensa Lung cancer
A review by Dr. Sivan Shamai on significant developments in the early-stage treatments of the disease
Oncology Lung cancer
A full overview on IMpower010 trial in eNSCLC
Oncology Tecentriq
Dr. Elizabeth Dudnik explains the treatment benefit for mNSCLC

Targeted Therapy in NSCLC
Oncology Alecensa
Lung cancer experts discuss the main publications from the European Society for Medical Oncology conference
Alecensa Lung cancer
Dr. Damian Urban and Dr. Sameh Daher discuss on disease management & treatment
Alecensa Lung cancer
Dr. Abed Agbarya and Dr. Walid Shalata discuss CPK elevation as predictor for response
Alecensa Oncology
Dr Ross et al in a panel discussion

SCLC
Oncology Tecentriq
The main publications that focus on the extensive stage and the different treatment strategies
Oncology Tecentriq
Presented by Prof. Rafal Dziadziuszko
Tecentriq Lung cancer
Changing the course of disease in ES-SCLC
You are about to leave Roche4Med website. Links to external web pages are offered for your convenience. Roche Pharmaceuticals (Israel) Ltd. is not responsible for the content displayed on those pages.